STO:RAY-B
RaySearch Laboratories AB (publ) · STO · Healthcare · SEK · FY for 2025
Figures on this page computed 2026-11-07 18:56 UTC
Last close
n/aSEK
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
26.6xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
- Computed from the filing for 2025
26.2%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
16.9%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
26.7%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
0.40Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
1.7%Dividend yield
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
6 of 6 traits placed on the market's range. Nothing sits below its sector's middle.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales1.64x
Its own average over 10 years, 818.1M.
- Profit2.59x
Its own average over 10 years, 87.8M.
- Free cash flow3.09x
Its own average over 10 years, 116.3M.
- Debt1.27x
Its own average over 10 years, 310.7M.
- Pricen/a
Its own average over 0 years. Market data
Free cash flow is furthest from its own average, at 3.09 times.
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2016-12-31 | 100.0 | 100.0 | 100.0 |
| 2017-12-31 | 110.1 | 77.7 | 100.0 |
| 2018-12-31 | 118.0 | 51.9 | 100.0 |
| 2019-12-31 | 139.5 | 33.3 | 100.0 |
| 2020-12-31 | 122.6 | -6.0 | 100.0 |
| 2021-12-31 | 120.7 | -31.3 | 100.0 |
| 2022-12-31 | 158.7 | 15.7 | 100.0 |
| 2023-12-31 | 192.3 | 53.9 | 100.0 |
| 2024-12-31 | 224.3 | 134.4 | 100.0 |
| 2025-12-31 | 252.9 | 150.5 | 99.9 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- SEK
How profit was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- SEK
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- SEK
Figures behind the shape
Growth
15.6%faster is higher, placed against 4,950 companies as of 2026-11-06
Five-year revenue growth rate15.6%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
One-year change in net income11.9%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
Returns on capital
26.2%higher is higher, placed against 5,089 companies as of 2026-11-06
Return on invested capital26.2%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity23.1%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets11.4%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Margins
70.8%wider is higher, placed against 3,412 companies as of 2026-11-06
Gross margin70.8%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin23.9%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin16.9%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin26.7%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Price
26.6xcheaper is higher, placed against 4,362 companies as of 2026-11-06
Price to earnings26.6x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
- Computed from the filing for 2025
Price to book6.1x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDA9.9x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio4.5x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
Safety
0.40safer is higher, placed against 3,227 companies as of 2026-11-06
Debt to equity0.40
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio1.70
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage41.3x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score5.75
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
What it pays out
1.7%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-06
Dividend yield1.7%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
Payout ratio45.1%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ratio3.5x
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- SEK
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.